ArticleThe British journal of ophthalmology2026
Epidemiology of pathologic myopia in UK adults with high myopia.
Article in The British journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial intelligence for pathologic myopia classification based on the META-PM system: a systematic review and meta-analysis.Frontiers in physiology · 2026Pooled it
- Strategies for the Prevention and Control of Complications of Pathological Myopia: A Systematic Review of Research Progress from Axial Control to Target Organ Protection.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
- Fundus Refraction Offset as an Individualized Myopia Biomarker.JAMA ophthalmology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo conduct the first cross-sectional epidemiological investigation of pathologic myopia (PM) in UK adults with high myopia.
methodsFundus photographs of 3024 highly myopic eyes (spherical equivalent refraction (SER) ≤-5.00D) from 2000 randomly sampled adults (aged 40-70 years) in the UK Biobank were double graded by an ophthalmic reading centre using the Meta-analysis for Pathologic Myopia framework. Adjudication was performed by one of two retinal specialists. Multivariable mixed-effects logistic regression was used to explore potential risk factors and fundus biomarkers-initially adjusting for SER, age and sex, before including these and other variables with p<0.10 in a single model.
resultsPM was present in 1138 of 3006 gradable fundus photographs, with 41.7% (95% CI 39.5% to 43.9%) of participants affected in at least one eye graded. Most eyes with PM exhibited diffuse chorioretinal atrophy (97.4%), while the more severe stages-patchy chorioretinal atrophy and macular atrophy-were observed in only 24 and 5 eyes, respectively. 13 eyes had 'plus' lesions or suspected staphyloma. Factors independently associated with increased odds of PM (all p<0.05) included decreasing SER (adjusted OR: 0.22, 95% CI 0.15 to 0.32), older age (2.20, 1.63 to 2.97), female sex (1.87, 1.12 to 3.12), lower deprivation (0.73, 0.56 to 0.94), white ethnicity (52.3, 17.3 to 158.3), lower retinal arteriovenous ratio (0.47, 0.37 to 0.58), increased retinal vascular complexity (4.60, 3.16 to 6.70) and a relatively horizontal disc orientation (2.98, 1.88 to 4.72). None of the explored modifiable lifestyle or health-related variables were associated with PM.
conclusionsPM prevalence is high among mid-life adults with high myopia in the UK Biobank, although most cases are relatively mild (diffuse chorioretinal atrophy). The only modifiable risk factor identified is myopia severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.